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Nickel(II)-promoted specific hydrolysis of zinc
finger proteins†
Agnieszka Belczyk-Ciesielska,a Brigitta Csipak,b Ba´lint Hajdu,b Aleksandra Sparavier,a
Masamitsu N. Asaka,c Kyosuke Nagata,c Be´la Gyurcsik *b and Wojciech Bal *a
In this work we demonstrate that the previously described reaction of sequence specific Ni(II)-dependent
hydrolytic peptide bond cleavage can be performed in complex metalloprotein molecules, such as the
Cys2His2 zinc finger proteins. The cleavage within a zinc finger unit possessing a (Ser/Thr)-X-His sequence
is not hindered by the presence of the Zn(II) ions. It results in loss of the Zn(II) ion, oxidation of the SH
groups and thus, in a collapse of the functional structure. We show that such natural Ni(II)-cleavage sites in
zinc finger domains can be edited out without compromising the DNA binding specificity. Inserting a
Ni(II)-susceptible sequence between the edited zinc finger and an affinity tag allows for removal of the
latter sequence by Ni(II) ions after the protein purification. We have shown that this reaction can be
executed even when a metal ion binding N-terminal His-tag is present. The cleavage product maintains the
native zinc finger structure involving Zn(II) ions. Mass spectra revealed that a Ni(II) ion remains coordinated
to the hydrolyzed protein product through the N-terminal (Ser/Thr)-X-His tripeptide segment. The fact that
the Ni(II)-dependent protein hydrolysis is influenced by the Ni(II) concentration, pH and temperature of the
reaction provides a platform for novel regulated DNA effector design.
Significance to metallomics
The present study shows that Cys2His2 zinc finger proteins including (S/T)XH sequence can be hydrolytically cleaved by Ni(II) ions. The cleavage involving any of
the histidines bound to Zn(II)-ions abolishes the functional structure of the affected finger. Designed Ni(II) sensitive sequences however, allow for removal of
affinity purification tags (even metal ion-binding oligo-His tag) or other regulatory fusion protein elements. Our study contributes to understanding of the effect
of Ni(II) ions on such a complex and sensitive metalloprotein. At the same time it opens a perspective for novel zinc finger fusion protein design which can be
activated/regulated by Ni(II)-induced cleavage.
Introduction
Transcription factors of the Cys2His2 zinc finger (ZF) family
control gene functions in living organisms by binding to
specific nucleic acid sequences.1,2 The canonical sequence of
a finger unit, able to form a bba secondary structure with a
tetrahedral metal ion binding site, was defined on the basis of
a library of native sequences as (Tyr,Phe)-X-Cys-X2,4-Cys-X3-Phe-
X5-Leu-X2-His-X3-5-His (Zn(II) binding residues underlined).
3 ZF
proteins possess a modular assembly in which each ZF unit
recognizes three subsequent nucleotides.1,2 This allows for
targeting DNA sequences of a 9–12 base pair length by a
cascade of such units in a ZF protein.4–9 Artificial ZF proteins
with desired DNA specificities can be obtained by altering the
amino acids in the a-helical DNA base recognition region
according to the well-known methodologies.10–14 A popular
approach is to utilize effector molecules (i.e. ligand or metal-
binding regulatory sequences or an endonuclease catalytic
domain) linked to ZF proteins, thereby providing an opportu-
nity to generate artificial transcription factors or enzymes for
specific DNA actions.2,15–25
Previously we reported on Ni(II)-induced peptide bond
hydrolysis that occurs at the N-terminal side of Ser or Thr
residues in peptides,26–36 designed recombinant proteins37,38
and flexible regions of native proteins37,39 bearing X-(Ser/Thr)-
X-His-X sequences (X being any amino acid except for Cys or
Pro before or after Ser/Thr). The method found application in
the affinity tag removal from fusion proteins by Ni(II) ions.37,38
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The cleavage is site specific and sequence selective making this
method unique among other approaches using metal ions.31,37,40
The molecular mechanism of this reaction was proposed
earlier31,35 and is depicted in Fig. S1 (ESI†). The formation of a
square planar Ni(II) complex is strictly required for the reaction: it
contains the Ni(II) ion bound to the imidazole nitrogen of the His
residue and three preceding amide nitrogens.31,35
Various human transcription factors contain potential Ni(II)
cleavage sites within their Cys2His2 ZF units. The 27 amino acid
long peptide, representing the 3rd ZF unit of the Sp1 human
transcription factor was shown to be cleaved by Ni(II) ions even
though the His residue crucial for the reaction was initially
complexed to the structural Zn(II) ion.32 The Zn(II) binding site
and the structure of the ZF unit was abolished in the reaction.
Naturally occurring Ni(II)-cleavage sites, which are present in
nearly 25% of human Cys2His2 ZF sequences
32 can thus be
considered potentially susceptible to hydrolysis upon the exposure
to Ni(II) ions naturally present in human tissues.41 Nickel is
absorbed through the diet, skin, lungs and then taken up by
cells.42,43 By analogy with the hydrolytic cleavage of histone
H2A observed in Ni(II)-exposed cell cultures, endogenous nickel
present in human cells may damage ZFs as part of its toxicity.
The knowledge, summarized above, inspired us to challenge
sequence specific Ni(II)-induced peptide bond cleavage within a
complex metalloprotein such as a Cys2His2-type classical ZF array
consisting of three ZF units and also possessing a Ni(II)-cleavable
N-terminal deka-His fusion tag. Our aim was to verify that the
binding of Zn(II) ions is unaffected by the presence of the Ni(II)
ions in the uncleaved finger units, i.e. they are not replaced by
Ni(II) ions and the oxidation of cysteines in the binding sites is
not catalysed by Ni(II) ions. We analysed and optimized the
cleavage of two ZF proteins by Ni(II) ions at a single peptide bond
between the protein and the affinity tag, and investigated the
structural integrity, as well as the Zn(II) and DNA binding properties
of the products by spectrometric and electrophoretic methods.
Materials and methods
Gene construction
Two ZF proteins, denoted by P-1MEY and P-1MEY# were
investigated, both consisting of three ZF units. The P-1MEY
protein is similar to that included in the ZF protein/DNA crystal
structure, with 1MEY PDB code,44 and the P-1MEY# ZF protein
is its modified version as described below. The gene of the
P-1MEY protein was ordered as a full length DNA with a stop
codon (IDT Japan Ltd) and ligated into a pET-16b vector
between the NdeI and BamHI sites. The gene of the P-1MEY#
protein was constructed starting from the above DNA sequence
by the modified QuikChanget site-directed mutagenesis method
(QCM, Stratagene, La Jolla, CA) using the following primers:
1MEY#-F (50-tcgccatcagcgtacccatac-30) and 1MEY#-R (50-accaggtt
atcgctgcgggaaaatgacttc-30) according to Scheme S1 (ESI†).
Consequently, a His was replaced with Asn (H99N) and a Ser
with Val (S101V). After the amplification of the DNA with KOD-FX
DNA polymerase (TOYOBO, Japan), the resulted DNA fragments
were treated by T4 polynucleotide kinase (TOYOBO, Japan) and
T4 ligase in the ligation high premix (TOYOBO, Japan). DH5a
cells were transformed with the resulted plasmid, and after the
DNA purification the success of the mutagenesis was verified by a
standard sequencing procedure.
Protein expression and purification
The P-1MEY and P-1MEY# proteins were expressed in BL21
(DE3) E. coli cells, which were cultured to OD of ca. 0.3, then the
protein expression was induced by 0.2 mM IPTG at 20 1C for
18 hours. Cells were collected and resuspended in a buffer
containing 500 mM NaCl, 100 mM HEPES (pH 8.2), and 10 mM
imidazole, and then sonicated. The pET-16b-P-1MEY and
pET-16b-P-1MEY# plasmids permitted introduction of the
N-terminal deka-His tag and thus, the expressed proteins were
subjected to Ni(II)-affinity chromatography as the main purification
step. Applying an imidazole concentration gradient in the eluent,
most of the target proteins were obtained at 300 mM imidazole as
shown in Fig. S2a (ESI†). The Zn(II) load of the ZF proteins was
verified by EDTA titration of the ZF proteins monitored by circular
dichroism spectroscopy (Fig. S2b, ESI†). The Zn(II) contents of the
purified ZF proteins were 3.0  0.2 equivalents/protein molecule.
Protein hydrolysis by Ni(II) ions
30–40 mM P-1MEY or P-1MEY# proteins were incubated with
400 mM Ni(II) (B10-fold molar excess) in a 100 mM HEPES
buffer with such an addition of Zn(II) that a 10–100 mM final
concentration of Zn(II) ions in excess of the protein remained in
solution. The conditions of the hydrolytic experiments varied
between 50 1C, pH 8.2 and 37 1C, pH 7.4 (i.e. close to physio-
logical conditions). Control reaction mixtures without Ni(II)
were incubated for 72 hours under the same conditions. All
samples were prepared and then incubated in low adsorption
1.5 ml tubes (LowBind, Eppendorf), using a thermoblock
(TB-941U, JW Electronic).
20 ml samples were collected from reaction mixtures at given
time points and the reactions were terminated by acidification
(2% TFA), as performed and justified before.35 Samples were
analysed by polyacrylamide gel-electrophoresis (Tricine-SDS-
PAGE45), and in parallel by HPLC (Breeze, Waters) using an
ACE C18 analytical column. The eluting solvent A was 0.1%
TFA/water and solvent B was 0.1% TFA/90% acetonitrile.
Electrospray ionization mass spectrometry (ESI-MS)
The samples investigated by ESI-MS (Premier, Q-Tof1, Waters)
were either obtained from the HPLC separation of the cleavage
products as described above (P-1MEY), or taken directly from
the reaction mixture (pH 8.2) with or without the sample
acidification to pHo4.0 (P-1MEY#). The samples were analysed
following a buffer exchange (to 100 mM NH4HCO3, pH 8.1) or
desalting on a RP-C18 pre-column (Waters).
Circular dichroism (CD) measurements
CD measurements were performed on a JASCO J-815 spectro-
polarimeter in quartz cuvettes (d = 2 mm or 0.1 mm). The spectra
were recorded in the 180–300 nm range, using 0.5 nm resolution,
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2 s response time, and scanning speed of 20 nm min1. The
samples were taken directly from the hydrolytic reactionmixture at
the beginning and after the termination of the reaction. The
solvent was exchanged to 5 mM phosphate buffer (pH 7.4) prior
to the CD experiment using an Amicon Ultra-0.5 Centrifugal Filter
Unit with Ultracel-3 membrane having a nominal molecular
weight limit of 3 kDa.
Electrophoretic mobility shift assay (EMSA)
The 1MEY+2bp oligonucleotide probe of the sequence 50-CG
TTCTGCCTCACTTTTGTGAGGCAGAACG-30, which included the
1MEY target sequence (underlined) and the ZFP#2+2bp probe
of the sequence 50-CGGGGATAGGCACTTTTGTGCCTATCCCCG-30
were used for EMSA experiments. These oligonucleotides were
labeled with [g-32P]ATP by T4 polynucleotide kinase (TOYOBO).
The labeled oligonucleotides were self-annealed, to yield the
double strand sequence stabilized by the TTTT loop, and then
purified from native PAGE, and used as probes. EMSA experiments
were performed in 10 ml of a 60 mM HEPES buffer, pH 8.2,
containing 10% (V/V) glycerol, 45 mM NaCl, 32P-end-labeled probe
(15 fmol) and P-1MEY or P-1MEY# protein at a concentration
giving rise to a protein excess between 0 and 100 fold, as indicated
in Fig. 1. The reaction mixtures were separated on a 6% (m/V)
polyacrylamide gel containing 12.5 mM Tris buffer and 96 mM
glycine. Radiolabeled probes were visualized by a BAS2000 imager.
Further EMSA experiments were carried out with a DNA probe
including four tandem copies (underlined) of the favourable 1MEY
binding sequence. It was constructed by the annealing and
subsequent prolongation of the following deoxy-oligonucletide
primers to yield a 72 bp DNA:
50-GGCGAATTCGAGGCAGAATGCTTATTCTGCCTCGAGCTCG
AG-30
50-GGCGAATTCGAGGCAGAATAAGCATTCTGCCTCGAGCTCG
AG-30. The DNA samples (cfinal = 4.0 mM) were incubated with
increasing amounts of the Ni(II)-cleaved P-1MEY# ZF protein from
1 : 1 to 1 : 4 molar ratio at pH 7.4 in a 100 mM HEPES buffer.
The reaction mixtures were separated on a 2% (m/V) agarose gel
and the DNA was visualized by the intercalated ethidium ion
fluorescence using an UviDoc gel documentation system.
Results and discussion
Choice and redesign of the ZF protein
The P-1MEY ZF protein sequence is based on the consensus
sequence CP-1 derived by Berg et al.,46 and confirmed by a recent
study,47 with the exception of the amino acids responsible for
DNA recognition. It is a well studied protein suitable for our
model cleavage experiments. The sequence was derived from a ZF
protein (denoted as P-1MEY-PDB) previously structurally char-
acterized in the complex with its cognate DNA (PDB code 1MEY).44
The amino acid sequences of the P-1MEY and mutant P-1MEY#
proteins investigated by us are aligned to the P-1MEY-PDB protein
in Scheme 1. The core sequence of P-1MEY responsible for the
functional structure and DNA recognition was kept intact. The
sequence was modified here by the deka-His tag at the N-terminus
for the purpose of affinity purification. Further amino acids,
following the affinity tag sequence were encoded by the pET-16b
plasmid: SSGH contains the underlined Ni(II)-sensitive sequence
and IEGR is the Factor Xa protease (NEB) recognition sequence.
Short extensions (additional amino acids compared to the
P-1MEY-PDB) at both termini of the P-1MEY protein sequence
(see Scheme 1) can be derived from the consensus sequence as
they are found in the Zinc Finger Tools program used for
protein redesign (vide infra).13
P-1MEY contains three X(S/T)XHX sequence motifs that can
undergo hydrolytic cleavage upon Ni(II)-binding. Two of them
are located close to each other within the DNA recognition region
of the 3rd ZF unit (similarly to the 3rd ZF unit of Sp1 – Scheme 1),
while the third sequence is located between the N-terminal
deka-His tag and the ZF protein sequence. Based on the
experiments with the Sp1 C-terminal peptide32 the possible
Ni(II)-dependent hydrolysis within the 3rd ZF unit of P-1MEY
may be expected to affect the properties of this finger. Therefore,
we redesigned P-1MEY ZF protein into P-1MEY# with a single
Ni(II)-sensitive sequence at the N-terminus, by editing out the
hydrolysable sequences in the 3rd finger.
Since the necessary substitutions fall within the DNA recognition
sequence, the Zinc Finger Tools program13 was utilized to maintain
the DNA binding specificity. For the target DNA sequence derived
from the 1MEY/DNA structure,44 the program yielded a ZF protein
sequence differing at various sites from the original one (Zinc Finger
Tools sequence in Scheme 1). To obtain the P-1MEY# protein we
introduced only the minimal changes limited to the 3rd ZF unit
involving the His to Asn (H99N) and Ser to Val (S101V) substitutions
(Scheme 1; see the Materials and methods section for details).
The DNA-binding specificity was maintained in the redesigned
ZF protein
The DNA binding properties of the P-1MEY-PDB ZF protein were
previously studied and the 50-GAGGCAGAA-30 DNA sequence
included in the 1MEY crystal structure was considered as a
Fig. 1 Electrophoretic mobility shift assay of the P-1MEY and P-1MEY#
proteins with the specific (1MEY+2 bp) and non-specific (ZFP#2+2 bp)
DNA probes.
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favourable binding site of the P-1MEY protein.44 After the expression
and purification procedures the DNA binding specificity of both
P-1MEY and the modified P-1MEY# ZF proteins was verified by
electrophoretic mobility shift assays (EMSA) using various short
DNA molecules. Fig. 1 shows that the modifications at the two
termini did not affect the DNA binding specificity of the P-1MEY
protein, and that the P-1MEY# mutant has recognition properties
comparable to the P-1MEY protein. P-1MEY# preferred to bind the
target DNA similarly to the original protein (see also Fig. S3, ESI†).
Besides, P-1MEY# was less prone to form non-specific complexes at
a 100-fold protein excess with the ZFP#2+2 bp non-specific DNA
probe, while under the same conditions the addition of P-1MEY
resulted in a shifted DNA band characteristic for this non-specific
DNA interaction. A small amount of such non-specific complex
between the P-1MEY protein and the 1MEY+2 bp specific DNA
probe was observed only at a high protein excess.
Monitoring the Ni(II)-induced hydrolysis of the ZF proteins
We verified the Ni(II)-cleavage for all susceptible sequences:
three in P-1MEY (SGH, SDH, SRH) and one in P-1MEY# protein
(SGH). The hydrolysis reactions were monitored by Tricine-SDS-
PAGE and products were analysed by HPLC.
The imidazole groups of the N-terminal deka-His tag have
the ability to complex Ni(II) ions and compete in this respect
with the His residue from the hydrolytic sequence X-(Ser/Thr)-
X-His-X. To overcome this effect we used at least a 10-fold molar
excess of Ni(II), as demonstrated before to be effective for
protein cleavage.37–39 The hydrolysis removes the His-tag, while
the catalytic Ni(II) ion remains coordinated to the (Ser/Thr)-X-His
motif of the protein (C-terminal product).
The CP-1 ZF peptide showed a high affinity towards Zn(II)
ions (KdB 2 pM),
46 and a recent re-investigation of ZF affinities
for Zn(II) ions indicated even lower Kd values.
48 Accordingly,
P-1MEY and P-1MEY# proteins were purified in their zinc-
loaded forms. Nevertheless, we used an additional amount of
Zn(II) ions (final excess: 10–100 mM) in each reaction mixture to
decrease the possibility of the Zn(II)/Ni(II) substitution in ZF
domains during the reaction. Metal ion substitution was suggested
to change the specificity of DNA recognition due to alteration of
the ZF structure, resulting from different coordination geometries
of these two metal ions.49 Change of the protein structure was also
supported in the presence of other metal ions, such as Cd(II) and
Hg(II),50 and the ZF cleavage was initiated by a dinuclear Pt(II)
complex initially replacing the Zn(II) ions from the thiolate sites.51
The structural integrity of P-1MEY and P-1MEY# proteins in
the presence and absence of Ni(II) ions was verified by CD spectro-
scopy upon iterative heating and cooling (from 10 1C to 50 1C and
back) of solutions adequate for the hydrolytic experiments. The
collapse of the structure of ZF proteins at high temperatures would
result in a disordered structure and thus, in an altered spectral
pattern, similar to that obtained for the apo-protein (Fig. S2b, ESI†).
It has to be noted here that this phenomenon was observed upon
addition of Cu(II) ions (unpublished results), but it was excluded
for Ni(II), as no significant changes were detected in the
presence of the latter metal ion in the intensity of the CD signal,
exemplified by the P-1MEY protein in Fig. S4 (ESI†).
Typically, three bands were observed in SDS PAGE after the
hydrolysis of the P-1MEY protein in the 10–15 kDa range,
corresponding to the substrate and the protein cleavage products,
and a further one appeared in the low molecular weight range,
corresponding to the short terminal peptide fragments (Fig. S5,
ESI†). The presence of distinct bands suggested that specific
cleavages occurred at least at two of three potential Ni(II) cleavage
sites. The sequence redesign process allowed P-1MEY# to be
Scheme 1 Amino acid sequences of ZF proteins applied in this study in aligned with related ZF sequences. P-1MEY-PDB: the protein used in the
crystallization study;44 P-1MEY: the original protein extended with a deka-His tag sequence for the purification purpose; P-1MEY#: the redesigned
protein with the ATCUN motif masked by the single Ni(II)-hydrolysable N-terminal sequence; ZF Tools: the protein predicted by the Zinc Finger Tools
program13 to recognize the specific 50-GAGGCAGAA-30 DNA sequence; ZF Tools (FS): the fixed sequences applied by the Zinc Finger Tools program
without the variable regions responsible for DNA recognition (denoted by XXXXXXX in each finger unit); Sp1: a ZF protein sequence having two Ni(II)
sensitive sites in the 3rd finger unit (similarly to the P-1MEY protein); CP-1 (2015): the 26 amino acids long consensus ZF peptide sequence found by
Goldberg et al.;47 CP-1: the 26 amino acids long consensus ZF peptide sequence established and investigated by Berg et al.46 Ni(II)-hydrolytic sites are
underlined and bolded, the conserved Zn(II)-binding sites are marked yellow, the modifications suggested by Zinc Finger Tools are marked light blue, and
the experimentally performed mutations are marked magenta.
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converted into a single high molecular weight hydrolysis product
(Fig. 2).
According to the kinetic analysis, the hydrolysis of the
P-1MEY# mutant protein occurred more slowly than that of
the P-1MEY (t1/2 = 30 h vs. 14 h at 37 1C and pH 8.2). The control
experiment without the Ni(II) ions revealed only a marginal
degradation of the protein after 72 h of incubation at the
elevated temperature and pH.
The Ni(II)-induced hydrolysis of P-1MEY and P-1MEY# ZFs
was investigated at 50 or 37 1C and pH 8.2 or 7.4 to demonstrate
the significant effect of the temperature and pH on the reaction
rate. The hydrolysis experiments repeated under physiological-
like conditions at 37 1C and pH 7.4 indicated that the reactivity
pattern was maintained, although the reaction rate decreased
significantly for both P-1MEY and P-1MEY#. The densitometric
results obtained from SDS PAGE gel analysis are shown in Fig. S6
(ESI†). These data were used to calculate reaction rate constants.
The comparison of t1/2 values in the 1
st order kinetic approxi-
mation revealed their strong pH dependence. We observed a
9-fold increase of the reaction rate between pH 7.4 and 8.2 at
37 1C (t1/2 ofB11 d, andB 30 h, respectively). The increase of the
temperature from 37 1C to 50 1C resulted in a further acceleration
of the reaction rate (t1/2 B 7.5 h). The pH dependence of the 1
st
order rate constant for the Ni(II)-assisted hydrolysis reaction has
a sigmoidal shape. The reaction rate is maximal at pH above
pH 8.2, where the square planar (4N) complex predominates.
At lower pH (pH 7.4) the extent of the formation of the active
4N complex is much lower: 20–80 times less, compared to
pH 8.2.31,52,53
Verification of the cleavage specificity and binding of the metal
ions by MS
The resolution of the gel electrophoresis is not sufficient to
precisely identify the hydrolytic cleavage sites. Therefore, we analysed
the reaction mixtures by ESI-MS. The experimentally determined
masses of the substrate proteins and their Ni(II)-hydrolysis
products agreed well with the theoretical predictions. Among
the P-1MEY products we identified short GHHHHHHHHHHS
and SRHQRTHTGKKTS N- and C-terminal peptides, respectively.
The peptide resulting from the cleavage at the SDH site,
SDHLSRHQRTHTGKKTS, was not detected as the cleavage
within the SRH sequence was much faster than that at SDH, as
predicted.32 However, the SDHL tetrapeptide was detected,
confirming that both SDH and the SRH cleavage sites were
hydrolytically active. The protein product after cleavage at both
SGH and SDH sites was also found (Table 1 and Table S1, ESI†).
These data revealed that the three Ni(II)-susceptible sequences
exerted different activities during the reaction with the Ni(II)
Fig. 2 Top: The electrophoretic analysis of the Ni(II)-dependent hydrolysis of
P-1MEY# ZF protein at 37 1C and pH 8.2; incubation times in hours (h),
S – substrate, P – product; D and M stand for the dimer and monomer,
respectively. Bottom: Kinetic plots of substrate formation (filled circles) and
product depletion (empty circles) in the hydrolysis reaction based on
the densitometric analysis of the Tricine-SDS-PAGE image considering
only the bands of the monomeric protein fractions. The red line represents
the fitting to the 1st order rate law.
Table 1 Products of Ni(II)-assisted hydrolysis of P-1MEY and P-1MEY#
identified by ESI-MS. SXH indicates the cleavage sites
Protein Cleavage site
MW experimental
(Da)
MW calculated (Da)
all-SS/all-SH
P-1MEYa — 13012 13006.3/13012.3
SRH (L)b 11 500c 11500.6/11506.6
SGH (L) 11 496d 11490.7/11496.7
11 743e 11743.5
SGH + SRH (L) 9986 9985.1/9991.1
SGH + SDH (L) 9532 9532.6/9538.6
9536f 9532.6/9538.6
9720g 9722,1
SRH (S) 1524 1523.6
SGH (S) 1534 1533.5
SDH (S) n.d. 1976.1
P-1MEY# — 13001 13001.3
SGH (L) 11 487d 11485.8
SGH (L) 11 733e 11732.6
a Separation of the P-1MEY cleavage products by HPLC was performed
under acidic conditions thus, the products did not contain complexed
metal ions. b (S) and (L) denote the small and large protein products of
the hydrolysis at each site. n.d., not detected. For the sequences see
Table S1 (ESI). c HPLC peak broadened due to the presence of various
oxidation products. The comparison of the calculated and measured
masses of the central large (L) protein portions yielded a 6 Da difference,
corresponding to oxidation of Cys residues to disulfides. d No oxidation
products were detected when the sample was directly taken from the
reactionmixture and immediately acidified. e The protein sample was not
acidified. The calculated mass reflected the coordination of 3 Zn(II) and
1 Ni(II) ions. f Oxidation of Cys residues within the destroyed finger unit
was detected when the sample was directly taken from the reaction
mixture and immediately acidified. g The protein sample was not
acidified. The calculated mass reflected the coordination of 2  Zn(II)
and 1  Ni(II) ions. Oxidation of cysteines within the destroyed finger
unit was detected.
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ion. The hydrolysis at the SDH site was the least favorable one,
consistently with previous studies on model peptides.30–32 The
mass of the final P-1MEY product of 9720 Da reflects the
coordination of 2  Zn(II) and 1  Ni(II) ions and the oxidation
of cysteines within the destroyed 3rd ZF unit, which lost the
Zn(II) ion binding ability after hydrolysis.
The ESI MS analysis of the P-1MEY# reaction products at
various pH confirmed the identity of the cleaved protein and its
metal binding status. The mass obtained under acidic conditions
corresponded well to that of the cleaved apoprotein. The mass
of the hydrolyzed P-1MEY# protein in a buffered solution was
11 733 Da (Table S1, ESI†). As the calculated mass of the
apoprotein is 11485.8 Da, it proves the coordination of three
Zn(II) ions within the ZF units and a Ni(II) ion at the N-terminal
ATCUN motif formed by the cleavage reaction (the calculated
mass of the holoprotein is 11733.6 Da). The thiolate oxidation
detected within the 3rd finger of the original P-1MEY was not
observed here due to the fact that the Zn(II) binding sites of
the redesigned P-1MEY# protein remained intact during the
hydrolytic process.
The functional structure is maintained in the Ni(II)-complexed
P-1MEY# cleavage product
Circular dichroism spectra of P-1MEY# were recorded before
and after the Ni(II)-induced hydrolysis, which resulted in the
N-terminal deka-His tag removal. The comparison of these
confirmed the preservation of the spectral pattern characteristic
for the folded solution structure of a Cys2His2 ZF unit
18,54 in the
cleavage product (Fig. 3), even though the reaction was carried
out at harsh conditions (50 1C and pH 8.2), and the buffer was
exchanged before the CD measurement.
The CD results further confirmed that unwanted modifications
such as the cleavage at non-specific sites, removal of Zn(II) ions or
oxidative damage of the protein did not occur to a detectable
extent in the modified P-1MEY# protein. The slight increase of
the CD intensity should be the consequence of the removal of the
short disordered N-terminal His-tag (GHHHHHHHHHHS). The
CD spectrum of the cleaved P-1MEY protein (Fig. S7, ESI†) is
practically identical to that of the intact P-1MEY. This suggests that
the ordering effect of the His-tag removal and the disordering
effect of the remnant peptide sequence after the cleavage of the 3rd
finger unit partially compensate for each other, and that the
structure of the two uncleaved ZF units was maintained during
the hydrolytic reaction in good agreement with the MS results. The
consequences of editing out the cleavage sites from the DNA
recognition region of P-1MEY in the Ni(II)-induced hydrolytic
peptide bond cleavage reaction are manifested in Fig. 4.
The question whether the Ni(II)-cleaved P-1MEY# is able to
recognize its cognate DNA was investigated by EMSA. The band
of the DNA molecule including four copies of the ZF recognition
site was already shifted in agarose gel upon addition of one molar
equivalent of the protein (Fig. 5). By increasing the protein excess a
second distinct shifted band appeared due to the binding of one or
more further protein molecules. At a fourfold excess of the protein
only the second band was observed. A smear was present to a
small extent attributed to minor non-specific binding – natural for
all ZF protein as a consequence of the electrostatic component of
their interactions with DNA. Similar phenomena were observed
with intact P-1MEY#, indicating that both proteins can interact
with the favourable DNA sequences equally effectively.
Fig. 3 Circular dichroism spectra of the P-1MEY# protein and its
Ni(II)-cleaved product in 5 mM phosphate buffer (pH 7.4) at 50 mM protein
concentration in a 0.1 mm quartz cell.
Fig. 4 Schematic representation of the Ni(II)-induced cleavage of P-1MEY and the redesigned P-1MEY# ZF proteins.
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Conclusion
We have tested for the first time the possibility of the specific
peptide bond hydrolysis induced by Ni(II) ions within two
complex His-tagged ZF metalloproteins without compromising
the original metal ion binding sites. The hydrolytic cleavage of
the two potential Ni(II)-cleavage sites within the 3rd finger was
not hindered by the presence of Zn(II) ions, but concomitantly
it abolished the Zn(II) binding site, resulting in loss of the
functional structure of this finger. Such partial cleavage of
a ZF type protein may lead to altered DNA binding causing
unwanted side-effects in cells. Under the applied conditions the
deka-His affinity tag did not interfere with the hydrolytic
peptide bond cleavage.
We redesigned the P-1MEY protein to edit out the naturally
occurring Ni(II) cleavage sites in the 3rd ZF unit and to obtain a
single N-terminal Ni(II)-catalytic site between the N-terminal
His-tag and the ZF protein sequence. The Zinc Finger Tools
programwas applied to design sequence changes without affecting
the DNA binding specificity. We confirmed experimentally that
the P-1MEY# protein maintained the Zn(II) and Ni(II)-binding
ability and a functional solution structure after the Ni(II)-
induced protein hydrolysis. This is crucial for any subsequent
applications.
Importantly, the Ni(II) ion remains coordinated to the (Ser/Thr)-
X-His motif in the C-terminal cleavage product. Such peptide
sequence, characterized by the presence of a His residue in
position 3 (referred to as ATCUN motif) provides strong
Cu(II) or Ni(II) binding and was shown to cleave DNA in the
presence of peroxides.55,56 Functionalization with DNA-binding
agents can enhance the efficiency or the selectivity of this
reaction,23,55,57–64 and may provide a chance for future treatment
of Ni(II)-dependent cancer utilizing the abundant Ni(II) ions
present there already.65–71
The advantage of our approach compared to previous reports
is that the ATCUN site of the ZF protein is initially masked by
the Ni(II) sensitive sequence, and can be activated and regulated
by the addition of Ni(II) ions, temperature jump or pH jump
(as the rate of the peptide bond cleavage itself is strictly dependent
on these three factors).30–32,37–39 Furthermore, the Ni(II) induced
peptide-bond hydrolysis can be applied for the removal of any
fusion proteins (such as affinity tags, inhibitory or activating
domains) from sensitive ZF metalloproteins. Thereby it provides
a chance for simple regulation and replacement of the expensive
specific protease enzymes. The N-terminal metal-binding site
may also promote the application of zinc fingers and eventually
their fusion variants as specific carriers of drugs or sensors
in their ternary complexes. Recently it has been reported that
the ATCUN motif can improve bioactivity of antimicrobial
peptides.72
Zinc finger proteins are potential biotechnological tools for
specific gene recognition and manipulation. Although the recent
competitive TALE and especially the CRISPR technologies prevail
this field,73–75 ZF protein based factors may still be attractive choice
for eukaryotic applications because of their complex protein–DNA
interface (the complexity of intra- and inter-finger interactions
allows one for discrimination between similar targets), small size,
human origin, as well as their low antigenicity. This is reflected in a
number of recent publications.65,76–78 In addition the method
described above can be generally applied for any engineered
protein, and by optimizing the Ni(II)-induced protein hydrolysis
to be significantly accelerated it may significantly contribute to
this field.
Abbreviations
[g-32P]ATP Adenosine triphosphate labelled with
radioactive phosphorus.
1MEY#-F Forward primer used during QCM to
create the gene of P-1MEY# protein.
1MEY#-R Reverse primer used during QCM to
create the gene of P-1MEY# protein.
1MEY The PDB code of a ZF protein in complex
with its specific DNA.
ATCUN Amino terminal copper and nickel
binding motif contains a His in the
third position from the N-terminal end
of the peptide/protein.
BamHI Type II restriction endonuclease isolated
from Bacillus amyloliquefaciens.
BL21 (DE3) Chemically competent E. coli cells suitable
for protein expression.
CD Circular dichroism.
CP-1 Consensus peptide 1.
CRISPR Clustered regularly interspaced short
palindromic repeats.
Cys2His2 Most commonly occurring Zn(II) binding
site donor set in ZF units.
DH5a Competent E. coli cells for cloning
applications.
EMSA Electrophoretic mobility shift assay.
Fig. 5 DNA binding of the Ni(II)-cleaved P-1MEY# ZF protein (denoted by
DP-1MEY#). A short double strand DNA including four tandem segments
of the favourable 50-GAGGCAGAA-30 sequence was applied in the EMSA
experiments. The intensity decrease at higher protein to DNA ratios is
presumably due to the impaired ability of the ethidium ion to bind the
protein-loaded DNA.
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ESI-MS Electron spray ionisation mass spectro-
metry.
Factor Xa Protease, which recognises IEGR amino
acid sequence and cleaves after the
arginine.
FokI Restriction endonuclease derived from
Flavobacterium okeanokoites.
H2A Histone protein involved in the structure
of chromatin in eukaryotic cells.
HEPES 4-(2-Hydroxyethyl)-1-piperazineethane-
sulfonic acid commonly used buffer in
biochemistry and molecular biology.
His-tag A dekahistidine-tag is an amino acid motif
in proteins that consists of ten histidine
(His) residues. The His-tag makes it
possible to purify the protein by Ni(II)-
affinity chromatography.
HPLC High-performance liquid chromatography.
IDT Integrated DNA technologiess.
IEGR Ile-Glu-Gly-Arg amino acid sequence.
IPTG Isopropyl b-D-1-thiogalactopyranoside
KOD-FX DNA polymerase from Toyobo Life Science
Department.
native PAGE Native polyacrylamide gel electrophoresis.
NdeI Type II restriction endonuclease isolated
from Neisseria denitrificans.
NEB New England Biolabss.
OD Optical density.
P-1MEY# Modified P-1MEY protein.
P-1MEY ZF protein similar to the P-1MEY-PDB
protein.
P-1MEY-PDB The ZF protein part of the 1MEY complex.
PDB (Protein Data Bank) library of crystal
structure data of proteins and protein–
DNA complexes.
pET-16b Cloning/expression vector carrying an
N-terminal HisTags sequence followed
by a Factor Xa site.
pET-16b-P-1MEY# pET-16b plasmid containing the gene of
P-1MEY# protein.
pET-16b-P-1MEY pET-16b plasmid containing the gene of
P-1MEY protein.
QuikChanget (QCM) Site-directed in vitro mutagenesis
method.
Sp1 A ZF-based transcription factor known
as Specificity Protein 1.
TALE Transcription activator-like effectors
proteins are secreted by Xanthomonas
bacteria infecting various plant species.
TFA 2,2,2-Trifluoroacetic acid.
Tricine-SDS-PAGE A tricine modified sodium-dodecyl-sulfate
polyacrylamide gel electrophoresismethod
for protein separation.
Tris Tris(hydroxymethyl)aminomethane
commonly used buffer in biochemistry
and molecular biology.
ZF unit A peptide ofB22–24 amino acids, having
a tetrahedral metal binding site within a
bba structure. Each unit recognises a
three nucleobase sequence.
ZF Zinc finger protein consisting of ZF units.
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